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ABSTRACT 
 
 
Obesity is the most common nutritional disorder in the United States and worldwide. Public 
health efforts and other anti-obesity measures clearly have not controlled the obesity epidemic. 
There is a great need to understand the pathogenic mechanisms underlying fat accumulation.  
Research of the past decade supports a prominent role for diet-induced adipose tissue 
dysfunction in the development and/or progression of obesity and associated insulin resistance. 
Potential mechanisms for the development of adipose tissue dysfunction include ectopic 
(visceral) fat accumulation, genetic factors, and alterations in autophagy and inflammatory 
processes. However, the molecular mechanisms linking dietary fat intake with alterations in 
adipose tissue autophagy levels are not well understood. A critical role of protein kinase C beta 
(PKC) in obesity-associated adipose dysfunction is emerging. PKC deficiency protects from 
high fat diet-induced obesity and related complications. High fat diet is also shown to induce 
adipose PKC expression in mice, whereas PKC deficiency is reported to stimulate autophagy 
in a cell culture model. Based on the above results, we hypothesized that high fat diet-induced 
PKC activation in the adipose tissue inhibits autophagy and thereby promotes adipose 
dysfunction and fat accumulation. We report here that high fat diet-induced adipose PKC 
induction is accompanied by a simultaneous reduction in the ratio of autophagy markers LC3-
II/LC3-I protein expression in mice. Importantly, high fat diet was unable to alter this ratio in the 
adipose tissue of PKC deficient mice. These results implicate PKC in mediating harmful 
effects of high fat diet on adipose tissue autophagy levels. It is hoped that understanding the 
PKC based pathogenic mechanisms leading to diet-induced adipose dysfunction will eventually 
lead to novel therapeutic approaches to combat the obesity epidemic. 
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ABBREVIATIONS USED 
 
HFD, high-fat diet; LC3, microtubule-associated protein 1 light chain 3; PKC, protein kinase C 
beta isoform; PKC-/-, protein kinase C-deficient mice; TG, triglycerides; WT, normal wild-
type mice; WAT, white adipose tissue (visceral fat). 
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INTRODUCTION 
 
A. Obesity rates are rising in USA and worldwide: 
The population of obese (defined as a body mass index of 30 or higher) individuals has increased 
dramatically during recent decades (Fig. 1). In 1980, obese adults constituted roughly 15 percent 
of the US population. By 2010, that number had risen to 36%, with roughly 69% the US 
population considered overweight (defined as a body mass index between 25 and 29.9) or obese 
(2). Most disturbing, is the fact that obesity rates have been steadily rising in children too. 
Roughly 17% of children and teens are obese and 33% are considered overweight or obese (3). 
As long as these trends continue, it has been predicted that about half of the US population will 
be obese in 15 years (4).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Trends in obesity prevalence in the United 
tates in the indicated period. This figure is taken 
from National Center for Health Statistics, part of the
Centers for Disease Control and Prevention.
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Obesity has become a worldwide phenomenon, now appearing in both developed and 
undeveloped countries. Globally, nearly 10 percent of men and 14 percent of women (roughly 
500 million adults) are estimated to be obese. Nearly three times as many are considered 
overweight or obese (5, 6). There is less data available on global obesity rates in children, but a 
recent global estimate found 43 million preschool children to be overweight or obese (7). If these 
trends continue, over 1 billion adults are estimated to be obese in 15 years (8).  
  
 Obesity is a major contributor to the worldwide problem of chronic diseases. Abdominal 
obesity in particular is suggested to play a central role in the development of obesity-related 
illness, such as type 2 diabetes mellitus and cardiovascular diseases (9). Thus, it is unsurprising 
that the incidence of obesity-associated disorders is also dramatically increasing and body fat and 
weight gain over time are effective predictors of type 2 diabetes (11). While the relationship 
between obesity, insulin resistance, and cardiovascular disease is well established (12), the 
mechanisms underlying this relationship are still not well understood.  It is estimated that the 
total cost of treating obesity-related diseases in the US is roughly $180 billion (13). 
 
B.  Energy imbalance and obesity: 
 Obesity is defined as an abnormal or excessive fat accumulation resulting from an imbalance 
between energy intake and energy expenditure. It is a complex polygenic disease that is caused 
by a number of lifestyle and environmental factors including: genetics, sedentary lifestyle, 
unhealthy diet, pregnancy, specific medications and sleep deficiency (15). 
 
 The combination of these factors results in a chronic positive energy imbalance, in which 
energy intake is greater than energy expenditure for an extended period of time. It is generally 
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believed that the development of obesity can be slowed down or avoided by modifying diet, 
exercise, and behavior habits. Even though it is estimated that 40-70% of the variation in body 
mass in a given population is a result of heritable factors (16, 17).   
 
C. Adipose tissue dysfunction in obesity:  
 Adipose tissue is the most variable organ in mammals in terms of size. At the extremes in 
humans, it ranges from a few percent of body weight in the malnourished to over 50% of total 
weight in the morbidly obese (14). This excessive accumulation of fat in different depots is 
associated with different metabolic consequences. Visceral fat creates a much greater risk of 
developing diabetes than does subcutaneous or peripheral fat (18). In fact, fat accumulation in 
the intra-abdominal visceral depot has been demonstrated to be an independent risk factor for the 
development of cardiovascular diseases and type 2 diabetes (19). The insulin sensitivity of 
visceral fat is different from that of subcutaneous adipose tissue (20). Lipids and other 
metabolites from visceral adipose tissue can be drained directly into the liver via the portal vein. 
Additionally, adipose and subcutaneous fat differ in their metabolism, gene expression and in 
secretion of hormones called adipokines (16). They are cell signaling cytokines which 
communicate with other tissues to modulate inflammation. Visceral adipose tissue 
predominantly secretes many pro-inflammatory cytokines, whereas anti-inflammatory 
adiponectin is highly expressed in subcutaneous fat (21).   
 
D.  Abnormal regulation of adipose tissue autophagy in obesity and diabetes:   
 Autophagy is responsible for the removal of malfunctioning organelles and misfolded 
proteins via lysosomes (22). It is activated in response to stress and various physiological stimuli. 
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Autophagy involves the formation of an autophagosome, a double-membrane cytoplasmic 
vesicle that engulfs cellular components and fuses with lysosomes for degradation. The 
formation of double-vesicle membrane is a complex process and involves more than 16 proteins. 
A critical step in autophagy is the covalent lipidation of microtubule-associated protein 1 light 
chain 3 (LC3) in which cleavage of LC3 allows a carboxy-terminal glycine to conjugate with 
phospholipids. This process is required for the formation of autophagosomes. Migration of 
lipidated LC3-II on SDS-PAGE gel monitors levels of autophagy at the cellular level. LC3-II 
moves faster than LC3-I because of its association with the phosphatidylethanolamine group. 
Commercial antibodies are available to measure expression of both LC3-I and LC3-II 
simultaneously by immunoblotting.  The above assay is generally used to measure cellular 
autophagy levels due to lack of a direct method to visualize autophagy in animal tissue. 
 
 Autophagy is considered a cellular degradation pathway essential for survival (23). As a 
protective mechanism, it safeguards organisms against normal and pathological conditions by 
regulating the turnover of dysfunctional organelles and proteins. Increasing evidence suggests 
that inhibition of autophagy greatly contributes to the accumulation of damaged organelles, 
leading to cell dysfunction or death. There are specific mechanisms for degradation of particular 
organelles; for example, mitochondria are degraded by autophagic mechanisms known as 
mitophagy (25). The efficiency of this process has been shown to decline with aging, and which 
can result in accumulation of damaged mitochondria (26, 27). The progressive decline of 
mitochondrial function is considered a major mechanism underlying obesity (25, 27-31). It is 
associated with less fatty acid oxidation and increased generation of reactive oxygen species, 
with detrimental structural and functional consequences.  
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Based on current knowledge, a model can be proposed to account for the development of 
obesity in response to complex interactions between genes, environment, and behavior (Fig. 2).  
 
 
  
 Fig. 2.  Proposed model of the pathogenesis of 
 diet-induced obesity.  The cascade of 
 pathogenic mechanism leads to adipose 
 dysfunction via reducing autophagy and 
 promoting accumulation of damaged 
 mitochondria and other organelles.  
 Compromised mitochondrial and cellular 
 functions result in ectopic lipid deposition 
 leading to the development of obesity and 
 related diseases. 
 
 
 
 
E.   Established role of protein kinase Cbeta in diet-induced obesity and diabetes:   
 Protein kinase Cbeta (PKC), a member of the lipid-activated serine/threonine PKC 
family, has recently been implicated as the master regulator of triglyceride homeostasis, 
possibly via regulating mitochondrial function (32). PKC plays a critical role in mediating 
deleterious effects of high-fat diet (HFD) on adipose functions: (i) HFD feeding of normal mice 
for 12 weeks induces PKC protein expression in the white adipose tissue (WAT), but does 
Genes Environment       Behavior
Excess dietary intake
Physical inactivity
Adipose autophagy
decreases
Accumulation of damaged
mitochondria and other organelles in WAT
Adipose tissue
dysfunction
Adipocyte hypertrophy
Fat deposition
Obesity
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not affect expression in either liver or muscle (33), (ii) whole‐body deficiency of PKC leads 
to leaner mice with significant reduction in body fat depots (32, 33) and these mice are resistant 
to diet‐induced obesity and obesity‐related metabolic complications such as type 2 diabetes 
(34), (iii) PKC‐/‐ adipocytes exhibit increased numbers of healthy mitochondria and higher 
levels of fatty acid oxidation than WT (32); (iv) PKC levels are elevated in the adipose tissue 
of leptin‐deficient ob/ob mice and PKC deficiency in these mice is also effective in reducing 
obesity and diabetes (34); (v) weight gain related to treatment with antipsychotic drugs in 
humans is linked to the activation of PKCexpression in adipose tissue (35); and (vi) 
Polymorphism in the PKC gene is associated with development of Type 2 diabetes and related 
complications (36, 37). The molecular mechanism underlying PKC action in the development 
of obesity is not known but the potential role of autophagy is indicated by a recent study in 
which overexpression of PKC in cultured cells (mouse embryo fibroblasts and human 
embryonic kidney cells) negatively regulated autophagy by influencing mitochondrial 
membrane potential (38). In view of relationships among reduced autophagy, increased 
mitochondrial dysfunction and development of obesity (27-31, 39, 40), it will be interesting to 
determine the role of PKC in regulating autophagy in the adipose tissue.  
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HYPOTHESIS 
 
 Feeding mice a HFD for 12 weeks induces adipose PKC expression (32), whereas PKC 
activation has been shown to inhibit autophagy in a cell culture system (34). Based on these 
observations, we hypothesize that HFD-induced PKCβ activation in the white adipose 
tissue (WAT) inhibits autophagy and thereby promotes adipose dysfunction and fat 
accumulation in mice leading to the development of obesity (Fig. 3). 
 
 
 
 
Fig. 3.  Outline of proposed hypothesis and expected results.  We propose that an increase in PKC 
expression mediates HFD-induced suppression of autophagy in adipose tissue and accounts for its obesity 
effects.  We expect to see relationships among adipose PKC levels, suppression of autophagy and 
accumulation of triglyceride levels in wild-type mice on HFD.  In contrast, HFD is not expected to 
suppress autophagy in the adipose tissue of PKC-/- mice.   
 
 To test the above hypothesis, we will examine the potential relationships among 
diet‐induced changes in adipose PKC expression, autophagy and fat accumulation upon 
feeding a HFD to WT and PKC-/- mice.   
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MATERIALS AND METHODS 
 
Animals and diet:  
Generation of mice deficient in whole-body PKC expression (PKC-/-) has been previously 
published (32-34). Six-week-old WT and PKC-/- male mice (n=6/genotype/diet group) were 
fed ad libitum either a HFD (60% of calories derived from fat; diet TD.06414 from Harlan 
Laboratories, IN) or a standard chow diet (17% of calories derived from fat; Harlan Tekland, 
WI) for 16 weeks (41, 42). Mice were housed under controlled temperature (23oC) and lighting 
(12 hours light/dark) with free access to water at the Ohio State University Animal Care Facility 
located in the Biomedical Research Tower. All procedures on mice followed guidelines 
established by the Ohio State University College of Medicine Animal Care Committee. At the 
end of 16 weeks, mice were anesthetized and sacrificed.  Body weight was measured for each 
mouse. WAT (visceral fat depot) from the above animals was dissected out, weighed, and 
immediately frozen in liquid nitrogen. The above procedures were carried out by lab 
personnel.  
 
 Immunoblotting:   
Frozen WAT (200 milligrams) samples was homogenized in lysis buffer (40 mM Tris-
HCl (pH 8.0), 150 mM NaCl, 0.5% sodium dodecyl sulfate, 0.5% sodium deoxycholate, 1% 
Triton X‐100, phosphatase and protease inhibitors). Protein concentrations were determined 
using a Pierce BCA protein assay kit (Life Technologies, CA). After adjusting the protein 
concentration, equal amount of protein (30 g/lane for -Actin, 50 g/lane for PKC, and 100 
g/lane for LC3s), along with colored molecular weight markers (BIO-RAD, CA), were 
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subjected to electrophoresis in SDS-polyacrylamide gels. Proteins were transferred to 
nitrocellulose membranes (BIO-RAD, CA) using a standard transfer buffer containing 20% 
methanol. Membranes were blocked with Tris buffer containing 5% (w/v) non‐fat dried milk 
for 1 hour. After washing with Tris buffer containg 500 mM NaCl and 0.05% (w/v) Tween 
20, the membrane was probed with a primary PKCβ antibody (1:500 dilution; Santa Cruz 
Biotechnology, CA) to visualize the kinetics of PKC (77 kDa) induction in the adipose tissue 
of wild‐type mice, or probed with LC3-1 and LC3-2  (16/18 kDa) antibody (1:250 
dilution; EMD Millipore, MA) to analyze the   expression levels of LC3 type 1 and 2 
proteins (as markers for autophagy levels) in the adipose tissues of WT and PKC‐/‐ mice, 
or using -Actin (42 kDa) antibody (1:2000 dilution; Santa Cruz Biotechnology, CA). After 
washing with buffer, the membranes were incubated with a secondary antibody conjugated to 
horseradish peroxidase (1:5000 dilution) (BIO-RAD, CA) for 1 hour. Immunoreactive protein 
bands were detected by using a SuperSignal substrate kit (Thermo Scientific Inc., IL). 
Immunoreactive bands of predicted molecular mass were quantified with BioRad GS-800 
calibrated densitometer using Quantify One analysis software (BIORAD, CA). Intensity of each 
band was corrected for background differences and normalized to -actin loading control. 
 
Statistical Analysis: 
Experiments were performed in order to analyze all the groups of animals in parallel, n 
representing the number of different individuals used in each group. Results are presented as 
mean+SD of the number of samples indicated. Student’s t-test was used when the values of two 
groups were analyzed. Data were considered statistically significant if P < 0.05. 
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RESULTS 
1.  PKC-/- mice gain less weight compared to WT mice in response to feeding a HFD.  
Both WT and PKC-/- mice were randomly divided into two groups. There were no significant 
differences in the initial body weights of these mice (Supplementary Data). One group was fed a 
chow diet and the other group was fed a HFD for 16 weeks, beginning at 6 weeks of age. At the 
end of the feeding period, body weight and WAT weight were examined for each mouse in both 
groups. It was observed that HFD feeding sharply increased body weights (43.58 ± 2.21 g WT 
versus 31.58 ± 1.4 g PKC-/-, n=6, p<0.001) (Fig. 4) and WAT depot weights (2.43 ± 0.23 g 
WT versus 0.76 ± 0.15 g PKC-/-, n=6, p<0.001) (Fig. 5 on next page) in WT mice compared to 
PKC-/- mice. 
 
 
 
 
 
 
 
Fig.  4.  PKC - / -  mice are resistant to HFD-induced obesity compared to WT mice.   
Comparison of body weights for WT and PKC - / -  mice fed ei ther a chow or HFD for 
16 weeks is  shown in the left  panel .   Results are expressed as mean+SD. n=6, ***, 
p<0.001. A representative picture of WT and PKC - / -  mice fed HFD for 16 weeks is 
shown in the right  panel.   
WT PKC-/-
Comparison of body size between 
HFD-fed WT and PKC-/- mice
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Fig.  5.  HFD dramatically increases WAT depot weight in WT mice compared to 
PKC - / -  mice.  Comparison of WAT weights for WT and PKC - / -  mice fed either a 
chow or HFD for 16 weeks is shown in the left  panel .  Results are expressed as 
mean+SD. n=6,  ***,  p<0.001.  A representat ive picture of  WATs of HFD-fed WT and 
PKC - / -  mice is  shown in the r ight panel.   
    
2. HFD induces adipose PKC expression in mice.  To determine PKC expression 
in the above WT mice, we compared PKC protein levels in the WAT of these mice 
after feeding either a chow or a HFD. It was observed that HFD feeding dramatically 
increased PKC expression (>13-fold) in the WAT of WT mice (Fig. 6). 
 
 
 
 
WT PKC-/-
Comparison of WAT size between 
HFD-fed WT and PKC-/- mice
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Fig. 6.  Effect of HFD feeding on adipose PKC expression.  WT mice fed a chow or a HFD were 
examined for proteins levels of PKC and -Actin (loading control) in the adipose tissue by 
immunoblotting using an antibody to each protein. The quantitation of the immunoblot is shown in the 
bottom panel. Each value represents the mean+SD. n=6, ***, p<0.001.    
 
3.  HFD reduces autophagy in adipose tissue of WT, but not in PKC-/- mice.  To 
determine if the change in adipose PKC expression was associated with an alteration in 
autophagy levels, we compared LC3 levels in the WATs obtained from WT mice fed a chow 
or a HFD. Autophagy level was determined as the change of the amount of the 
autophagosomal membrane marker LC3-II compared to LC3-I in vivo. This can serve as the 
indicator of autophagy intensity. The relative ratio of LC3-II/LC3-I protein expression is 
significantly reduced in the WAT of WT mice fed a HFD compared to WAT obtained from 
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mice fed a chow diet (Fig. 7). Quantitation of changes in LC3-II/LC3-I levels (normalized to 
-actin levels) indicated that the autophagy levels have been reduced by almost 59%. To 
determine the effect of PKC deficiency on HFD-dependent suppression of autophagy levels, 
we also compared the relative protein expression of LC3-I and LC3-II in the adipose tissues of 
PKC-/- mice fed either a chow or HFD. Interestingly, feeding a HFD to PKC-/- mice had no 
significant effect on the ratio of LC3-II/LC3-I protein expression and was found to be 
comparable to mice fed a chow diet (Fig. 8).  
 
 
 
 
 
 
 
 
 
 
Fig. 7.  Effect of HFD feeding on the relative protein expression of LC3-I and LC3-II in WT mice.  
WT mice fed a chow or HFD were examined for LC3-I, LC3-II, and -Actin protein levels in the 
adipose tissue by immunoblottting using an antibody to each protein. The quantitation of the 
immunoblot is shown in the bottom panel.  Each value represents the mean+SD.  n=6, **,  p<0.01.   
 
-Actin
LC3-II
LC3-I
Chow HFD
42 kDa
18 kDa
16 kDa
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Fig. 8.  Effect of HFD on relative protein expression of LC3-I and LC3-II in PKC-/- mice fed 
either a chow or a HFD for 16 weeks. PKC-/- mice fed either a chow diet or a HFD were examined 
for LC3-I, LC3-II, and -Actin protein levels in the adipose tissue by immunoblottting using an 
antibody to each protein. Quantitation of immunoblot is shown in the bottom panel. Each value 
represents the mean+SD.  n=6, (p=0.55).     
  
 
 
 
 
Chow
PKC-/- mice
-Actin
HFD
42 kDa
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DISCUSSION AND CONCLUSIONS 
 
The results presented above highlight a novel role of PKC in regulating HFD-dependent 
suppression of adipose autophagy levels. We show that HFD-induced adipose PKC activation 
(Fig. 6) is accompanied by a simultaneous decrease in adipose autophagy levels in WT mice 
(Fig. 7). Most importantly, HFD was unable to significantly affect adipose autophagy levels in 
PKC-/- mice (Fig. 8), providing strong support for a novel role of PKC in regulating 
autophagy levels in vivo. Our observation that HFD reduces adipose autophagy levels is in 
agreement with recent reports that feeding HFD reduces autophagy and in WAT of WT mice, 
but the underlying mechanism was not investigated in their studies (43, 44). A defect in 
autophagic activity was also recently identified in liver tissues of insulin-resistant mice, and the 
correction of autophagy by genetic means was sufficient to restore the hepatic responsiveness to 
insulin, thus also supporting a strong link between defective autophagy and obesity-associated 
insulin resistance (45). Given that PKC deficiency protects from diet-induced obesity and 
diabetes (34), our results are also in agreement with the notion that defective regulation of 
autophagy could be one of the mechanisms linking caloric overload to the development of 
insulin resistance. It is important to note in this regard that common glucose-lowering 
medications, including metformin and thiazolidinediones, have also been shown to stimulate 
autophagy (46, 47). Lastly, an increase in autophagy has been recently shown to be required for 
the beneficial effects of exercise on glucose and lipid metabolism (48). 
 
Several lines of evidence implicate mitochondrial dysfunction as a major contributor to 
obesity (27-31). It is likely that damaged mitochondria not only oxidize fat inefficiently, but 
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also generate large amounts of reactive oxygen species which are known to disrupt cellular 
function. Our results suggest that diet-dependent PKC activation contributes to a reduction 
in autophagic activity, which can exacerbate the accumulation of harmful cellular “garbage” 
including defective mitochondria. Failure to remove damaged mitochondria by a reduction in 
“mitophagy” is expected to make adipocytes store extra calories as triglyceride more 
efficiently (27-31, 39, 40). 
 
 Can a therapeutic strategy targeting adipose PKC be effective in treating dietary fat-induced 
obesity and diabetes? Given that whole body PKC deficiency is associated with protection from 
obesity possibly by increasing the percentage of healthy mitochondria in adipose tissue (25-27), 
it is possible that PKC deficiency exerts this effect through promoting mitophagy. Thus 
stimulating autophagy seems to be an attractive approach to improve adipose tissue adaptation to 
the caloric load. Before such a possibility is considered further, an important question to be 
answered is the specific contribution of adipose PKC deficiency to the lean phenotype of 
PKC-/- mice. One approach to answering this question is by studying the sole contribution of 
adipose-specific PKC deficiency to the lean phenotype of PKC-/- mice by generating tissue-
specific mice using an inducible expression system (49, 50).   
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